TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Feb 28, 2023 | (FY)Aug 31, 2022 | (Q6)Feb 28, 2022 | (FY)Aug 31, 2021 | (Q6)Feb 28, 2021 | (FY)Aug 31, 2020 | (Q6)Feb 29, 2020 | (FY)Aug 31, 2019 | (Q6)Feb 28, 2019 | (FY)Aug 31, 2018 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | -47.32%5.72M | ---- | 88.90%10.86M | ---- | -32.42%5.75M | ---- | 24.89%8.5M | ---- | 270.57%6.81M |
Profit adjustment | ||||||||||
Attributable subsidiary (profit) loss | ---- | 433.33%16K | ---- | -25.00%3K | ---- | -20.00%4K | ---- | 108.06%5K | ---- | -160.19%-62K |
Impairment and provisions: | ---- | -81.13%994K | ---- | 156.73%5.27M | ---- | 413.28%2.05M | ---- | -450.27%-655K | ---- | 334.88%187K |
-Impairmen of inventory (reversal) | ---- | ---- | ---- | 233.82%5.26M | ---- | 293.61%1.58M | ---- | -731.01%-814K | ---- | 3,125.00%129K |
-Other impairments and provisions | ---- | 14,100.00%994K | ---- | -98.53%7K | ---- | 199.37%476K | ---- | 174.14%159K | ---- | 48.72%58K |
Revaluation surplus: | ---- | -21.46%183K | ---- | --233K | ---- | ---- | ---- | ---- | ---- | ---- |
-Derivative financial instruments fair value (increase) | ---- | -21.46%183K | ---- | --233K | ---- | ---- | ---- | ---- | ---- | ---- |
Asset sale loss (gain): | ---- | 800.00%7K | ---- | 99.62%-1K | ---- | 85.84%-261K | ---- | -6,045.16%-1.84M | ---- | -95.00%31K |
-Loss (gain) on sale of property, machinery and equipment | ---- | 800.00%7K | ---- | 99.62%-1K | ---- | 85.84%-261K | ---- | -6,045.16%-1.84M | ---- | 34.78%31K |
Depreciation and amortization: | ---- | 14.98%16.47M | ---- | 9.43%14.32M | ---- | 51.77%13.09M | ---- | 73.31%8.62M | ---- | 30.16%4.98M |
Financial expense | ---- | -6.04%7.17M | ---- | -7.19%7.63M | ---- | 52.38%8.22M | ---- | 25.35%5.4M | ---- | 71.95%4.3M |
Unrealized exchange loss (gain) | ---- | -76.32%622K | ---- | 295.75%2.63M | ---- | 39.82%-1.34M | ---- | -75.45%-2.23M | ---- | -415.38%-1.27M |
Special items | ---- | 45.83%-13K | ---- | ---24K | ---- | ---- | ---- | ---- | ---- | ---- |
Operating profit before the change of operating capital | ---- | -23.83%31.17M | ---- | 48.73%40.92M | ---- | 54.55%27.51M | ---- | 18.87%17.8M | ---- | 327.46%14.97M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | 110.39%4.44M | ---- | -1,061.89%-42.69M | ---- | 12.08%-3.67M | ---- | 76.84%-4.18M | ---- | -239.68%-18.04M |
Accounts receivable (increase)decrease | ---- | -230.54%-22.87M | ---- | 186.84%17.52M | ---- | -166.91%-20.18M | ---- | 59.99%-7.56M | ---- | 3.60%-18.9M |
Accounts payable increase (decrease) | ---- | 320.02%7.44M | ---- | -121.05%-3.38M | ---- | 254.40%16.06M | ---- | -339.14%-10.4M | ---- | -72.50%4.35M |
Cash from business operations | ---- | 63.09%20.17M | ---- | -37.29%12.37M | ---- | 554.54%19.72M | ---- | 75.37%-4.34M | ---- | -214.97%-17.62M |
Other taxs | ---- | -135.36%-3.18M | ---- | -62.30%-1.35M | ---- | -14.74%-833K | ---- | -10.33%-726K | ---- | -37.08%-658K |
Interest paid - operating | ---- | ---- | ---- | ---- | ---- | 16.28%-288K | ---- | -82.01%-344K | ---- | -28.57%-189K |
Special items of business | 130.75%32.55M | ---- | -39.71%14.1M | ---- | 133.47%23.39M | ---- | 173.79%10.02M | ---- | 41.07%-13.58M | ---- |
Net cash from operations | 130.75%32.55M | 54.22%16.99M | -39.71%14.1M | -40.78%11.01M | 133.47%23.39M | 443.88%18.6M | 173.79%10.02M | 70.71%-5.41M | 41.07%-13.58M | -196.83%-18.46M |
Cash flow from investment activities | ||||||||||
Loan receivable (increase) decrease | ---- | 66.67%-3K | ---- | ---9K | ---- | ---- | ---- | ---- | ---- | ---- |
Sale of fixed assets | ---- | -85.36%134K | ---- | 101.54%915K | ---- | -75.39%454K | ---- | 6,262.07%1.85M | ---- | 141.67%29K |
Purchase of fixed assets | ---- | 54.77%-5.71M | ---- | -23.97%-12.62M | ---- | 57.65%-10.18M | ---- | 5.12%-24.03M | ---- | -341.08%-25.33M |
Cash on investment | ---- | ---- | ---- | ---- | ---- | -64.00%1.8M | ---- | 238.54%5M | ---- | -63.75%-3.61M |
Other items in the investment business | 15.33%-1.76M | ---- | 17.24%-2.07M | ---- | 51.06%-2.51M | 600.00%15K | -341.47%-5.12M | -160.00%-3K | 87.07%-1.16M | 110.87%5K |
Net cash from investment operations | 15.33%-1.76M | 52.39%-5.58M | 17.24%-2.07M | -48.08%-11.71M | 51.06%-2.51M | 54.00%-7.91M | -341.47%-5.12M | 40.52%-17.19M | 87.07%-1.16M | -261.78%-28.91M |
Net cash before financing | 155.94%30.79M | 1,734.67%11.41M | -42.41%12.03M | -106.53%-698K | 326.37%20.89M | 147.29%10.69M | 133.24%4.9M | 52.29%-22.6M | 53.96%-14.74M | -233.35%-47.37M |
Cash flow from financing activities | ||||||||||
New borrowing | ---- | -6.28%817.37M | ---- | 310.55%872.13M | ---- | -19.36%212.43M | ---- | 64.44%263.44M | ---- | 776.27%160.2M |
Refund | ---- | 4.76%-810.91M | ---- | -325.74%-851.47M | ---- | 14.58%-200M | ---- | -101.02%-234.13M | ---- | -1,109.49%-116.47M |
Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 557.30%43.04M |
Interest paid - financing | ---- | 6.04%-7.17M | ---- | 3.82%-7.63M | ---- | -57.06%-7.93M | ---- | -22.75%-5.05M | ---- | -74.66%-4.12M |
Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---2.77M |
Other items of the financing business | -323.31%-32.04M | ---- | 53.90%-7.57M | ---- | -6.11%-16.42M | 116.74%153K | -344.82%-15.47M | 92.87%-914K | -107.41%-3.48M | -305.86%-12.82M |
Net cash from financing operations | -323.31%-32.04M | -3,222.95%-13.76M | 53.90%-7.57M | 91.08%-414K | -6.11%-16.42M | -123.87%-4.64M | -344.82%-15.47M | -69.87%19.45M | -107.41%-3.48M | 608.42%64.55M |
Effect of rate | -22.12%-1.28M | 217.71%1.76M | -267.04%-1.05M | 31.35%-1.49M | 202.28%628K | -144.04%-2.17M | -70.08%-614K | -7.62%-890K | ---361K | ---827K |
Net Cash | -127.95%-1.25M | -111.06%-2.35M | -0.22%4.46M | -118.39%-1.11M | 142.30%4.47M | 291.72%6.05M | 41.97%-10.57M | -118.36%-3.15M | -221.86%-18.22M | 437.03%17.18M |
Begining period cash | -4.88%11.55M | -17.65%12.14M | -17.65%12.14M | 35.65%14.75M | 35.65%14.75M | -27.11%10.87M | -27.11%10.87M | 1,135.76%14.92M | 1,135.76%14.92M | -139.37%-1.44M |
Cash at the end | -42.00%9.02M | -4.88%11.55M | -21.62%15.56M | -17.65%12.14M | 6,400.32%19.85M | 35.65%14.75M | 91.40%-315K | -27.11%10.87M | -127.12%-3.66M | 1,135.76%14.92M |
Cash balance analysis | ||||||||||
Cash and cash equivalent balance | ---- | ---- | ---- | ---- | ---- | ---- | 91.40%-315K | ---- | -127.12%-3.66M | ---- |
Currency Unit | MYR | MYR | MYR | MYR | MYR | MYR | MYR | MYR | MYR | MYR |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.